Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Medicare Program; Calendar Year (CY) 2025 Home Health Prospective Payment System (HH PPS) Rate Update; HH Quality Reporting Program Requirements; HH Value-Based Purchasing Expanded Model Requirements; Home Intravenous Immune Globulin (IVIG) Items and Services Rate Update; and Other Medicare Policies".

119-hjres58 — Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Medicare Program; Calendar Year (CY) 2025 Home Health Prospective Payment System (HH PPS) Rate Update; HH Quality Reporting Program Requirements; HH Value-Based Purchasing Expanded Model Requirements; Home Intravenous Immune Globulin (IVIG) Items and Services Rate Update; and Other Medicare Policies".. Sponsored by Rep. Clyde, Andrew S. [R-GA-9]. Introduced 2025-02-12. House bill. 119th Congress. Latest action: Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

119-hjres58 119th Congress House
XML

Bill Activity

House
Introduced in House
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsor
Rep. Clyde, Andrew S. [R-GA-9] (R), GA
Introduced
2025-02-12
Committees
Energy and Commerce Committee; Ways and Means Committee
Subjects
Administrative law and regulatory procedures; Blood and blood diseases; Cardiovascular and respiratory health; Congressional oversight; Department of Health and Human Services; Health care costs and insurance; Health technology, devices, supplies; Home and outpatient care; Long-term, rehabilitative, and terminal care; Medicare
Latest Action
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

No roll-call vote data available for this bill.

Explore This Bill

Investigate this bill → AI summary, roll-call breakdown, and full bill analysis